O	0	10	Recruiting
O	11	14	and
O	15	24	retaining
O	25	31	breast
O	32	38	cancer
O	39	48	survivors
O	49	53	into
O	54	55	a
O	56	66	randomized
O	67	77	controlled
B-intervention	78	86	exercise
O	87	92	trial
O	92	93	:
O	94	97	the
O	98	102	Yale
O	103	111	Exercise
O	112	115	and
O	116	128	Survivorship
O	129	134	Study
O	134	135	.

O	136	141	Given
O	142	155	observational
O	156	164	findings
O	165	169	that
O	170	178	physical
O	179	187	activity
O	188	195	reduces
O	196	202	breast
O	203	209	cancer
O	210	214	risk
O	214	215	,
O	216	224	improves
O	225	233	survival
O	233	234	,
O	235	238	and
O	239	247	improves
O	248	255	quality
O	256	258	of
O	259	263	life
O	264	266	in
O	267	273	breast
O	274	280	cancer
O	281	290	survivors
O	290	291	,
O	292	293	a
O	294	298	need
O	299	302	has
O	303	307	been
O	308	318	identified
O	319	322	for
O	323	333	randomized
O	334	344	controlled
O	345	351	trials
O	352	356	that
O	357	361	test
O	362	365	the
O	366	374	efficacy
O	375	377	of
O	378	386	exercise
O	387	389	on
O	390	400	biological
O	401	411	mechanisms
O	412	422	associated
O	423	427	with
O	428	434	breast
O	435	441	cancer
O	442	450	survival
O	450	451	.

O	452	455	The
O	456	463	primary
O	464	468	aims
O	469	471	of
O	472	475	the
O	476	480	Yale
O	481	489	Exercise
O	490	493	and
O	494	506	Survivorship
O	507	512	Study
O	513	517	were
O	518	520	to
O	521	522	1
O	522	523	)
O	524	533	determine
O	534	537	the
O	538	549	feasibility
O	550	552	of
O	553	563	recruiting
O	564	570	breast
O	571	577	cancer
O	578	587	survivors
O	588	592	into
O	593	594	a
O	595	605	randomized
O	606	616	controlled
O	617	622	trial
O	623	625	of
O	626	629	the
O	630	637	effects
O	638	640	of
O	641	649	exercise
O	650	652	on
O	653	663	biological
O	664	671	markers
O	672	675	and
O	675	676	/
O	676	678	or
O	679	689	mechanisms
O	690	700	associated
O	701	705	with
O	706	714	survival
O	714	715	,
O	716	717	2
O	717	718	)
O	719	726	compare
O	727	730	the
O	731	744	effectiveness
O	745	747	of
O	748	755	various
O	756	767	recruitment
O	768	778	strategies
O	779	781	on
O	782	789	accrual
O	790	795	rates
O	796	799	and
O	800	808	baseline
O	809	824	characteristics
O	824	825	,
O	826	829	and
O	830	831	3
O	831	832	)
O	833	839	report
O	840	849	adherence
O	850	852	to
O	853	856	the
O	857	865	exercise
O	866	871	trial
O	871	872	.

B-total-participants	873	880	Seventy
I-total-participants	880	881	-
I-total-participants	881	885	five
B-eligibility	886	900	postmenopausal
I-eligibility	901	907	breast
I-eligibility	908	914	cancer
I-eligibility	915	924	survivors
O	925	929	self
O	929	930	-
O	930	938	referred
O	939	943	into
O	944	947	the
O	948	953	trial
O	954	956	or
O	957	961	were
O	962	971	recruited
O	972	979	through
O	980	983	the
O	984	987	New
O	988	993	Haven
O	994	999	Tumor
O	1000	1001	[
O	1001	1010	corrected
O	1010	1011	]
O	1012	1020	Registry
O	1021	1024	and
O	1025	1033	randomly
O	1034	1042	assigned
O	1043	1045	to
O	1046	1048	an
O	1049	1057	exercise
O	1058	1059	(
O	1059	1060	n
O	1061	1062	=
B-intervention-participants	1063	1065	37
O	1065	1066	)
O	1067	1069	or
B-control	1070	1075	usual
I-control	1075	1076	-
I-control	1076	1080	care
O	1081	1082	(
O	1082	1083	n
O	1084	1085	=
B-control-participants	1086	1088	38
O	1088	1089	)
O	1090	1095	group
O	1095	1096	.

O	1097	1100	The
O	1101	1109	exercise
O	1110	1115	group
O	1116	1128	participated
O	1129	1131	in
O	1132	1135	150
O	1136	1139	min
O	1139	1140	/
O	1140	1142	wk
O	1143	1145	of
O	1146	1156	supervised
O	1157	1160	gym
O	1160	1161	-
O	1161	1166	based
O	1167	1170	and
O	1171	1175	home
O	1175	1176	-
O	1176	1181	based
O	1182	1189	aerobic
O	1190	1198	exercise
O	1199	1202	for
O	1203	1204	6
O	1205	1211	months
O	1211	1212	.

O	1213	1216	The
O	1217	1222	usual
O	1222	1223	-
O	1223	1227	care
O	1228	1233	group
O	1234	1237	was
O	1238	1248	instructed
O	1249	1251	to
O	1252	1260	maintain
O	1261	1268	current
O	1269	1277	physical
O	1278	1286	activity
O	1287	1292	level
O	1292	1293	.

O	1294	1295	A
O	1296	1301	total
O	1302	1304	of
B-total-participants	1305	1307	75
O	1308	1313	women
O	1314	1315	(
O	1315	1317	an
O	1318	1325	accrual
O	1326	1330	rate
O	1331	1333	of
O	1334	1335	9
O	1335	1336	.
O	1336	1337	5
O	1337	1338	%
O	1338	1339	)
O	1340	1344	were
O	1345	1355	randomized
O	1356	1358	to
O	1359	1362	the
O	1363	1368	trial
O	1368	1369	.

O	1370	1375	Rates
O	1376	1378	of
O	1379	1386	accrual
O	1387	1391	were
O	1392	1398	higher
O	1399	1402	for
O	1403	1408	women
O	1409	1412	who
O	1413	1417	self
O	1417	1418	-
O	1418	1426	referred
O	1427	1431	into
O	1432	1435	the
O	1436	1441	study
O	1442	1443	(
O	1443	1445	19
O	1445	1446	.
O	1446	1447	8
O	1447	1448	%
O	1448	1449	)
O	1450	1458	compared
O	1459	1463	with
O	1464	1469	women
O	1470	1479	recruited
O	1480	1483	via
O	1484	1487	the
O	1488	1494	cancer
O	1495	1503	registry
O	1504	1505	(
O	1505	1506	7
O	1506	1507	.
O	1507	1508	6
O	1508	1509	%
O	1509	1510	)
O	1510	1511	;
O	1512	1519	however
O	1519	1520	,
O	1521	1532	demographic
O	1532	1533	,
O	1534	1545	physiologic
O	1545	1546	,
O	1547	1550	and
O	1551	1561	prognostic
O	1562	1577	characteristics
O	1578	1581	did
O	1582	1585	not
O	1586	1592	differ
O	1593	1600	between
O	1601	1604	the
O	1605	1606	2
O	1607	1618	recruitment
O	1619	1629	strategies
O	1629	1630	.

O	1631	1633	On
O	1634	1641	average
O	1641	1642	,
O	1643	1653	exercisers
O	1654	1663	increased
B-outcome	1664	1672	moderate
I-outcome	1672	1673	-
I-outcome	1674	1683	intensity
I-outcome	1684	1686	to
I-outcome	1687	1695	vigorous
I-outcome	1695	1696	-
I-outcome	1696	1705	intensity
I-outcome	1706	1713	aerobic
I-outcome	1714	1722	exercise
O	1723	1725	by
B-iv-cont-mean	1726	1729	129
I-iv-cont-mean	1730	1737	minutes
O	1738	1741	per
O	1742	1746	week
O	1747	1755	compared
O	1756	1760	with
B-cv-cont-mean	1761	1763	44
I-cv-cont-mean	1764	1771	minutes
O	1772	1775	per
O	1776	1780	week
O	1781	1786	among
O	1787	1792	usual
O	1792	1793	-
O	1793	1797	care
O	1798	1810	participants
O	1811	1812	(
O	1812	1813	P
O	1814	1815	<
O	1816	1817	.
O	1817	1820	001
O	1820	1821	)
O	1821	1822	.

O	1823	1828	Women
O	1829	1831	in
O	1832	1835	the
O	1836	1844	exercise
O	1844	1845	-
O	1845	1857	intervention
O	1858	1863	group
O	1864	1873	increased
O	1874	1879	their
B-outcome	1880	1887	average
I-outcome	1888	1897	pedometer
I-outcome	1898	1903	steps
O	1904	1906	by
B-iv-cont-mean	1907	1911	1621
I-iv-cont-mean	1912	1917	steps
O	1918	1921	per
O	1922	1925	day
O	1926	1934	compared
O	1935	1939	with
O	1940	1941	a
O	1942	1950	decrease
O	1951	1953	of
B-cv-cont-mean	1954	1956	60
I-cv-cont-mean	1957	1962	steps
O	1963	1966	per
O	1967	1970	day
O	1971	1976	among
O	1977	1982	women
O	1983	1985	in
O	1986	1989	the
O	1990	1995	usual
O	1995	1996	-
O	1996	2000	care
O	2001	2006	group
O	2007	2008	(
O	2008	2009	P
O	2010	2011	<
O	2012	2013	.
O	2013	2015	01
O	2015	2016	)
O	2016	2017	.

O	2018	2026	Findings
O	2027	2031	from
O	2032	2036	this
O	2037	2042	study
O	2043	2047	will
O	2048	2055	provide
O	2056	2062	useful
O	2063	2074	information
O	2075	2078	for
O	2079	2092	investigators
O	2093	2096	who
O	2097	2100	are
O	2101	2111	conducting
O	2112	2120	exercise
O	2121	2127	trials
O	2128	2130	in
O	2131	2137	cancer
O	2138	2149	populations
O	2149	2150	,
O	2151	2161	clinicians
O	2162	2165	who
O	2166	2169	are
O	2170	2178	treating
O	2179	2184	women
O	2185	2194	diagnosed
O	2195	2199	with
O	2200	2206	breast
O	2207	2213	cancer
O	2213	2214	,
O	2215	2218	and
O	2219	2227	exercise
O	2228	2241	professionals
O	2242	2245	who
O	2246	2249	are
O	2250	2260	developing
O	2261	2270	community
O	2270	2271	-
O	2271	2276	based
O	2277	2285	exercise
O	2286	2294	programs
O	2295	2298	for
O	2299	2305	cancer
O	2306	2315	survivors
O	2315	2316	.
